www.worldbulletin.net |
Lilly Delays Diabetes Treatment Submission
Wall Street Journal Eli Lilly and Co. said Monday that it would hold off on submitting its late-stage diabetes treatment to both U.S. and European regulatory agencies for approval until it better understands the treatment's potential side effects. Basal insulin peglispro … Lilly delays submission to market once-daily diabetes drugwww.worldbulletin.net Eli Lilly's BIL Filing Delayed, Baricitinib Scores in Phase IIIZacks.com Eli Lilly's BIL Filing Delayed, Baricitinib Scores in Phase III – Analyst BlogNasdaq CNNMoney –MarketWatch all 53 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.